Cargando…
Heparin failure and COVID-19: Should we explore other anticoagulants? An observational report regarding in-vitro recovery of anticoagulant action in COVID-19 patients in intensive care
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415167/ https://www.ncbi.nlm.nih.gov/pubmed/32795720 http://dx.doi.org/10.1016/j.thromres.2020.08.010 |
_version_ | 1783569116505833472 |
---|---|
author | Thomas, W. White, D. Cox-Morton, S. MacDonald, S. Besser, M. |
author_facet | Thomas, W. White, D. Cox-Morton, S. MacDonald, S. Besser, M. |
author_sort | Thomas, W. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7415167 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-74151672020-08-10 Heparin failure and COVID-19: Should we explore other anticoagulants? An observational report regarding in-vitro recovery of anticoagulant action in COVID-19 patients in intensive care Thomas, W. White, D. Cox-Morton, S. MacDonald, S. Besser, M. Thromb Res Letter to the Editors-in-Chief Elsevier Ltd. 2020-11 2020-08-09 /pmc/articles/PMC7415167/ /pubmed/32795720 http://dx.doi.org/10.1016/j.thromres.2020.08.010 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editors-in-Chief Thomas, W. White, D. Cox-Morton, S. MacDonald, S. Besser, M. Heparin failure and COVID-19: Should we explore other anticoagulants? An observational report regarding in-vitro recovery of anticoagulant action in COVID-19 patients in intensive care |
title | Heparin failure and COVID-19: Should we explore other anticoagulants? An observational report regarding in-vitro recovery of anticoagulant action in COVID-19 patients in intensive care |
title_full | Heparin failure and COVID-19: Should we explore other anticoagulants? An observational report regarding in-vitro recovery of anticoagulant action in COVID-19 patients in intensive care |
title_fullStr | Heparin failure and COVID-19: Should we explore other anticoagulants? An observational report regarding in-vitro recovery of anticoagulant action in COVID-19 patients in intensive care |
title_full_unstemmed | Heparin failure and COVID-19: Should we explore other anticoagulants? An observational report regarding in-vitro recovery of anticoagulant action in COVID-19 patients in intensive care |
title_short | Heparin failure and COVID-19: Should we explore other anticoagulants? An observational report regarding in-vitro recovery of anticoagulant action in COVID-19 patients in intensive care |
title_sort | heparin failure and covid-19: should we explore other anticoagulants? an observational report regarding in-vitro recovery of anticoagulant action in covid-19 patients in intensive care |
topic | Letter to the Editors-in-Chief |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415167/ https://www.ncbi.nlm.nih.gov/pubmed/32795720 http://dx.doi.org/10.1016/j.thromres.2020.08.010 |
work_keys_str_mv | AT thomasw heparinfailureandcovid19shouldweexploreotheranticoagulantsanobservationalreportregardinginvitrorecoveryofanticoagulantactionincovid19patientsinintensivecare AT whited heparinfailureandcovid19shouldweexploreotheranticoagulantsanobservationalreportregardinginvitrorecoveryofanticoagulantactionincovid19patientsinintensivecare AT coxmortons heparinfailureandcovid19shouldweexploreotheranticoagulantsanobservationalreportregardinginvitrorecoveryofanticoagulantactionincovid19patientsinintensivecare AT macdonalds heparinfailureandcovid19shouldweexploreotheranticoagulantsanobservationalreportregardinginvitrorecoveryofanticoagulantactionincovid19patientsinintensivecare AT besserm heparinfailureandcovid19shouldweexploreotheranticoagulantsanobservationalreportregardinginvitrorecoveryofanticoagulantactionincovid19patientsinintensivecare |